Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]

Fair value was estimated at grant date using the weighted-average assumptions listed below:


	Three months ended June 30,
	2020	2019

Dividend Yield	—%	—%
Expected Volatility	55.10%	49.74%
Average risk-free rate	0.43%	2.22%
Expected Life	6.2 years	6.6 years

Summary schedule of stock option activity

ption activity for the three months ended June 30, 2020 was as follows:


	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value

Options outstanding, beginning of period	646,728	$	88.30
Granted during period	300	59.02
Exercised during period	—	—
Forfeited during period	(5,940)	100.79
Expired during period	(300)	76.51
Options outstanding, end of period	640,788	$	88.17	6.2 years	$	1,020,150
Options exercisable, end of period	324,369	$	75.19	4.2 years	$	1,018,200

Summary of the status and changes restricted stock

A summary of the status of the Company’s restricted stock as of June 30, 2020, and changes during the three months ended June 30, 2020, are presented below:


	Shares	Weighted Average Fair Value at Grant Date

Outstanding at March 31, 2020	705,254	$	101.47
Granted during the period	2,055	59.02
Vested during the period	(6,271)	108.87
Forfeited during the period	(30,000)	100.79
Outstanding at June 30, 2020	671,038	$	101.30

Tabular disclosure of performance shares vesting based on EPS targets [Table Text Block]

The Performance Share performance targets are set forth below.


Trailing 4-Quarter EPS Targets for September 30, 2018 through March 31, 2025			Restricted Stock Eligible for Vesting (Percentage of Award)
$16.35			40%
$20.45			60%